Paroxetine exposure during pregnancy and the risk of cardiac malformations: What is the evidence?
✍ Scribed by Anick Bérard
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 65 KB
- Volume
- 88
- Category
- Article
- ISSN
- 1542-0752
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND Treatment of asthma symptoms during pregnancy is crucial for maternal and fetal health. Short‐acting beta~2~‐agonists (SABA) are frequently used as rescue medications and long‐acting beta~2~‐agonists (LABA) are used as add‐on controller therapy for asthma during pregnancy
## Abstract **BACKGROUND:** In spite of the widespread use of antihypertensives during pregnancy, data on their risks and benefits for the newborn are limited. We investigated the risk of major congenital malformations or small‐for‐gestational‐age newborns (SGA) in relation to gestational use of an
## Background The concern that maternal exposure to electomagnetic fields (EMF) might be related to childhood cancer risks, particularly leukemia risks. Methods Maternal occupational data already collected as part of the Oxford Survey of Childhood Cancers have been reviewed. Information on occupat